InvestorsHub Logo
Followers 6
Posts 1087
Boards Moderated 0
Alias Born 07/18/2006

Re: None

Saturday, 03/19/2022 6:14:15 PM

Saturday, March 19, 2022 6:14:15 PM

Post# of 17422
Bristol Myers Squibb: Still On Track

Mar. 19, 2022 8:40 AM ET
Bristol-Myers Squibb Company (BMY)
Summary
Despite facing a steep patent cliff, BMY has one of the largest pipelines of the US pharmaceuticals. Recent and upcoming launches should replace lost revenue to support continued modest growth.
The market is overly focused on upcoming patent cliffs and undervaluing the pipeline.
Strong cash flow enables BMY to pay off debt incurred from recent Celgene and MyoKardia acquisitions, as well as offer shareholder returns.


https://seekingalpha.com/article/4496603-bristol-myers-squibb-on-track?mailingid=27087168&messageid=must_reads&serial=27087168.1300418&utm_campaign=Must%2BRead%2BMarch%2B19%2C%2B2022&utm_content=seeking_alpha&utm_medium=email&utm_source=seeking_alpha&utm_term=must_reads

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News